Recherche
-
Effect of Baseline Subretinal Fluid on Treatment Outcomes in VIVID-DME and VISTA-DME Studies
(Ophthalmology Retina. vol. 3, n° 8, pp. 663-669, 2019-08)Article de revueLibre accès -
Lower limb events in individuals with type 2 diabetes: evidence for an increased risk associated with diuretic use
(Diabetologia. vol. 62, n° 6, pp. 939-947, 2019-06)Article de revueLibre accès -
Subfoveal Choroidal Thickness, Cardiovascular History, and Risk Factors in the Elderly: The Montrachet Study
(Investigative ophthalmology & visual science. vol. 60, n° 7, pp. 2431-2437, 2019)Article de revueLibre accès -
Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease
(Nature Genetics. vol. 51, n° 11, pp. 1574-1579, 2019-11-01)Article de revueLibre accès -
Health administrative data enrichment using cohort information: Comparative evaluation of methods by simulation and application to real data.
(PLoS ONE. vol. 14, n° 1, pp. e0211118, 2019-01-01)Article de revueLibre accès -
Health administrative data enrichment using cohort information: Comparative evaluation of methods by simulation and application to real data
(PLoS ONE. vol. 14, n° 1, pp. e0211118, 2019-01-31)Article de revueLibre accès -
SmartCRF: A Prototype to Visualize, Search and Annotate an Electronic Health Record from an i2b2 Clinical Data Warehouse
(Stud Health Technol Inform. vol. 264, pp. 1445-1446, 2019-08-21)Article de revueLibre accès -
Retention in Care Trajectories of HIV-Positive Individuals Participating in a Universal Test-and-Treat Program in Rural South Africa (ANRS 12249 TasP Trial)
(Journal of acquired immune deficiency syndromes (1999). vol. 80, n° 4, pp. 375-385, 2019-04-01)Article de revueLibre accès -
Using healthcare claims data to analyze the prevalence of BCR-ABL-positive chronic myeloid leukemia in France: A nationwide population-based study
(Cancer Medicine. vol. 8, n° 6, pp. 3296-3304, 2019-06)Article de revueLibre accès -
Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial Fibrillation
(Stroke. vol. 50, n° 9, pp. 2469-2476, 2019)Article de revueLibre accès